Pharma: Novartis shares dropped 9% following setbacks in three clinical trials for its drug candidates.
Novartis shares plummeted on Tuesday following disappointing results from the del-desiran drug trial, leaving investors concerned. 📉💔 #Novartis #InvestingNews #Pharma
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
